证券代码：603987 证券简称：康德莱 公告编号：2025-036 上海康德莱企业发展集团股份有限公司 关于董事会换届选举的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 上海康德莱企业发展集团股份有限公司（以下简称"公司"）第五届董事会 原定任期至 2026 年 2 月 1 日届满，因公司战略规划和经营管理需要，根据《公 司法》《上海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引 第 1 号——规范运作》等法律法规、规范性文件及《公司章程》的有关规定，董 事会拟提前进行换届选举工作。现将本次董事会换届选举的相关事项情况公告如 下： 一、董事会换届选举情况 公司于 2025 年 12 月 3 日召开了第五届董事会第二十次会议，审议通过了《关 于上海康德莱企业发展集团股份有限公司董事会换届选举非独立董事候选人的 议案》《关于上海康德莱企业发展集团股份有限公司董事会换届选举独立董事候 选人的议案》，上述议案尚需提交公司 2025 年第三次临时股东会审议。公司第六 届董事会由九名董事组成，其中独立董事三名 ...

证券代码：603987 证券简称：康德莱 公告编号：2025-032 上海康德莱企业发展集团股份有限公司 第五届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 上海康德莱企业发展集团股份有限公司（以下简称"公司"）第五届董事会 第二十次会议（以下简称"会议"）于 2025 年 12 月 3 日在上海市嘉定区高潮路 658 号会议室以现场结合通讯表决方式召开，会议通知及相关会议文件于 2025 年 11 月 27 日以电子邮件方式向全体董事和高级管理人员发出。会议应出席董事 9 名，实际出席董事 9 名。会议由董事长张宪淼先生主持，公司财务总监、董事 会秘书列席会议。本次会议符合《中华人民共和国公司法》《上海证券交易所股 票上市规则》等有关法律、行政法规、部门规章、规范性文件和《上海康德莱企 业发展集团股份有限公司章程》的规定。 二、董事会会议审议情况 （一）审议通过了《关于确定 2026 年公司及子公司申请银行授信额度的议 案》； 根据公司及子公司 2026 年的经营规划和业 ...

Market Overview - The medical consumables supply chain SPD sector experienced a decline of 1.42% on November 19, with Ailong Technology leading the drop [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Stock Performance - Key stocks in the medical consumables supply chain SPD sector showed mixed performance, with Jianfa Zhixin rising by 3.19% to a closing price of 34.00, while several others, including Guoyao Yici and Jiuzhoutong, saw declines of 0.55% and 0.59% respectively [1] - The trading volume and turnover for Jianfa Zhixin were 180,800 hands and 620 million yuan, respectively [1] Capital Flow - The medical consumables supply chain SPD sector saw a net outflow of 99.05 million yuan from main funds, while retail investors contributed a net inflow of 74.72 million yuan [2] - Notable individual stock capital flows included Jianfa Zhixin with a net inflow of 70.39 million yuan from main funds, while Ailong Technology experienced a net outflow of 2.99 million yuan [3]

Core Viewpoint - 康德莱's stock price has shown a year-to-date increase of 32.29%, but it has recently experienced a slight decline in the short term [2]. Group 1: Stock Performance - As of November 17, 康德莱's stock price decreased by 2.11% to 9.30 yuan per share, with a trading volume of 21.77 million yuan and a turnover rate of 0.53%, resulting in a total market capitalization of 4.062 billion yuan [1]. - In the past five trading days, 康德莱's stock has dropped by 1.06%, while it has increased by 1.97% over the last 20 days and 4.49% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, 康德莱 reported a revenue of 1.721 billion yuan, reflecting a year-on-year growth of 0.95%, and a net profit attributable to shareholders of 194 million yuan, which is a 17.27% increase year-on-year [3]. - Since its A-share listing, 康德莱 has distributed a total of 530 million yuan in dividends, with 231 million yuan distributed over the past three years [4]. Group 3: Shareholder and Institutional Holdings - As of September 30, 2025, 康德莱 had 34,100 shareholders, an increase of 29.67% from the previous period, with an average of 12,826 circulating shares per shareholder, down by 22.88% [3]. - Among the top ten circulating shareholders, 招商成长量化选股股票A and 医疗器械ETF are new entrants, holding 2.4635 million shares and 1.8815 million shares, respectively [4].

Core Points - The company held its second extraordinary general meeting of shareholders on November 13, 2025, with no resolutions being rejected [2] - The meeting was presided over by the vice chairman, and all procedures complied with relevant laws and regulations [2][3] Meeting Attendance - Out of 9 current directors, 5 attended the meeting, while the chairman and three other directors were absent due to work commitments [3] - All 3 current supervisors attended the meeting, along with the board secretary and the financial director [3] Resolutions Reviewed - Multiple amendments to the company's articles of association and various internal rules were approved, including changes to the shareholder meeting rules, board meeting rules, and the management of fundraising [4][5][6] - The resolution to abolish the supervisor meeting rules was also passed [5] Legal Witnessing - The meeting was witnessed by lawyers from DeHeng Law Offices, who confirmed that all procedures and resolutions were in compliance with legal requirements [6]

证券代码：603987 证券简称：康德莱 公告编号：2025-031 上海康德莱企业发展集团股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 215 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 183,309,610 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份 | 41.9673 | | 总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由副董事长陈红琴女士主持，公司部分董事、全体监事、部分高 级管理人员及见证律师等相关人员出席会议。会议程序符合《公司法》等相关法 律法规、部门规章、规范性文件和《公司章程》的规定。 (五) 公司董事、监事和董事会秘书的出席情况 (一) 非累积投票 ...

德恒上海律师事务所 关于 上海康德莱企业发展集团股份有限公司 2025 年第二次临时股东会之 见证意见 上海市东大名路 501 号上海白玉兰广场办公楼 23 层 电话：021-55989888/55989666 传真：021-5598 9898 邮编：200080 德恒上海律师事务所 关于上海康德莱企业发展集团股份有限公司 2025 年第二次临时股东会之见证意见 见证意见 德恒 02G20170018-00035 号 致：上海康德莱企业发展集团股份有限公司 德恒上海律师事务所接受上海康德莱企业发展集团股份有限公司（以下或称 "公司"）的委托，指派本所见证律师对公司于 2025 年 11 月 13 日 10:00 召开 的 2025 年第二次临时股东会（以下简称"本次股东会"）进行见证并出具本见 证意见。 本所见证律师依据本见证意见出具日前已经发生或存在的事实和《中华人民 共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以 下简称"《证券法》"）、《上市公司股东会规则》（以下简称"《股东会规则》"） 等现行有效的法律、法规和规范性文件以及《上海康德莱企业发展集团股份有限 公司章程》（以下简称 ...

Core Viewpoint - The company is actively working on its business operations in the fourth quarter while also planning and budgeting for next year's operational goals and preparations [2] Group 1 - The company is making continuous efforts to advance its business operations during the fourth quarter [2] - The company is in the process of planning and budgeting for its operational goals for the upcoming year [2] - Preparations for various operational activities for next year are being arranged and deployed [2]

Core Viewpoint - The company is actively monitoring domestic and international industry trends while effectively executing its strategic goals, enhancing its operational capabilities across market, research and development, and manufacturing sectors [1] Group 1 - The company is focused on continuously consolidating and improving its operations [1]

Core Viewpoint - The company, Kangdelai (603987), stated that its operations are normal, and fluctuations in customer orders and turnover rates are within a controllable range [1] Group 1 - The company confirmed that its business operations are functioning normally [1] - Customer orders are experiencing fluctuations, but these are deemed normal and manageable [1] - The turnover rates are also within a controllable range, indicating stability in operations [1]